All forms of Zantac have been recalled as of April 2020. Push Mitteilungen FN als Startseite. Losartan Tablets. Manufacturers and exporters of bulk drugs, formulations, and oral suspensions. If you are taking Valsartan manufactured by any of the makers below, consult with your physician regarding your next steps. In December 2018, Torrent Pharmaceuticals began a voluntary recall of losartan due to the presence of small traces of known carcinogens. The Sandoz Inc. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. NDMA has also been found in Zantac (ranitidine) heartburn medication. Aurobindo Pharma Limited and COVAXX, a US-based company, have entered into an Exclusive License Agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and the United Nations Children’s Fund (UNICEF) agency. RELATED: Aurobindo gets warning letter over valsartan recall mess. On July 2, 2020, it was announced that Major Pharmaceuticals issued a consumer-level recall on Metformin Hydrochloride Extended-Release 500mg Tablets, 10×10 Unit Dose with NDC #00904-5794-61. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. And in November, Mylan Pharmaceuticals also issued a voluntary recall of some of its Amlodipine and Valsartan products for the same reason. This time, the recall affects 5 lots: 3 lots of losartan potassium tablets and 2 lots of losartan/hydrochlorothiazide tablets. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Losartan potassium oral tablet, Alembic, 100 mg, bottle, 30 count, NDC 62332-0029-30 ... and Torrent were affected by the recall. Products Affected - Description. Artikel bewerten: (1) Aurobindo … Additional information can be found at https://www.fda.gov/Safety/Recalls/ucm625492.htm. Cadista has losartan/hydrochlorothiazide tablets available. The recall was issued due to one lot of Metformin being tested and showed results for NDMA levels in excess of the Acceptable Daily Intake Limit. Losartan Potassium Tablets 100 mg – 1000/Bottle View Details: ... Aurobindo adds value through superior customer service in the distribution of a broad line of generic pharmaceuticals, leveraging vertical integration and efficient controlled processes. Contact. Update ... 11/30/2020: 13668-118-90: Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 count. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. © 2019 CBS Interactive Inc. All Rights Reserved. Hyzaar oral tablet, Merck, 100 mg/ 12.5 mg, bottle, 30 count, NDC 00006-0745-31, Hyzaar oral tablet, Merck, 100 mg/ 12.5 mg, bottle, 90 count, NDC 00006-0745-54, Hyzaar oral tablet, Merck, 100 mg/ 25 mg, bottle, 30 count, NDC 00006-0747-31, Hyzaar oral tablet, Merck, 100 mg/ 25 mg, bottle, 90 count, NDC 00006-0747-54, Hyzaar oral tablet, Merck, 50 mg /12.5 mg, bottle, 30 count, NDC 00006-0717-31, Hyzaar oral tablet, Merck, 50 mg/ 12.5 mg, bottle, 90 count, NDC 00006-0717-54, Losartan and Hydrochlorothiazide oral tablet, Cadista, 100 mg/ 12.5 mg, bottle, 30 count, NDC 59746-0338-30, Losartan and Hydrochlorothiazide oral tablet, Cadista, 100 mg/ 25 mg, bottle, 30 count, NDC 59746-0339-30, Losartan and Hydrochlorothiazide oral tablet, Cadista, 100 mg/ 25 mg, bottle, 90 count, NDC 59746-0339-90, Losartan and Hydrochlorothiazide oral tablet, Cadista, 100 mg/ 25 mg, bottle, 90 count, NDC 59746-0338-90, Losartan and Hydrochlorothiazide oral tablet, Cadista, 50 mg/ 12.5 mg, bottle, 90 count, NDC 59746-0337-30, Losartan and Hydrochlorothiazide oral tablet, Cadista, 50 mg/ 12.5 mg, bottle, 90 count, NDC 59746-0337-90, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 12.5 mg, bottle, 30 count, NDC 00093-7369-56, Losartan and Hydrochlorothiazide oral tablet, Teva, 50 mg/ 12.5 mg, bottle, 30 count, NDC 00093-7367-56, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 12.5 mg, bottle, 30 count, NDC 13668-0117-30, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 12.5 mg, bottle, 90 count, NDC 13668-0117-90, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 13668-0117-10, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 25 mg, bottle, 30 count, NDC 13668-0118-30, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 25 mg, bottle, 90 count, NDC 13668-0118-90, Losartan and Hydrochlorothiazide oral tablet, Torrent, 100 mg/ 25 mg, bottle, 1000 count, NDC 13668-0118-10, Losartan and Hydrochlorothiazide oral tablet, Torrent, 50 mg/ 12.5 mg, bottle, 30 count, NDC 13668-0116-30, Losartan and Hydrochlorothiazide oral tablet, Torrent, 50 mg/ 12.5 mg, bottle, 90 count, NDC 13668-0116-90, Losartan and Hydrochlorothiazide oral tablet, Torrent, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 13668-0116-10, Alembic has losartan and hydrochlorothiazide tablets on allocation to contracted customers. In July 2018, the FDA announced a voluntary recall of several drugs containing valsartan, used to treat high blood pressure and heart failure, because of contamination with an impurity, the potentially cancer-causing chemical N-nitrosodimethylamine, or NDMA. However, patients should consult with their pharmacist or physician who can advise them on alternative treatments. Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the drug substance Irbesartandue to the presence of an impurity, N-nitrosodiethylamine (NDEA). Manufacturers face thousands of lawsuits from Zantac users who claim their cancer was caused by the contaminated drug. The Valsartan Recall List. Company Announcement. The impurity involves a chemical called N-nitrosodiethylamine (NDEA), which the FDA describes as a "substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen.". Lupin and Sandoz did not provide a reason for the shortage. Aurobindo refuses to provide updated availability information. A recall of the product was instigated on July 29, 2019. Inauguration Live Updates: President Biden moves quickly to implement agenda, Watch Live: Inauguration Day events after Biden is sworn in, Biden signs executive actions on first day as president, Senate confirms Biden's first Cabinet nominee, Amanda Gorman reads the inaugural poem "The Hill We Climb", Kamala Harris wears Black designers at inauguration, Biden extends student loan payment freeze, Trump defends his record, says "we'll be back" in farewell speech, Biden, in inaugural address, implores Americans to "end this uncivil war", U.S. allies "greatly relieved," but also wary as Biden steps up, Amanda Gorman makes history as youngest inaugural poet, Trump defends his record and says "we'll be back" in farewell speech, FDA expands recall on blood pressure drug, Blood pressure medication recall expanded, Joe Biden's "Day One" actions and his promises for his first 100 days, Quitting smoking by 40 may give you lost life back, Doubling up on masks could help keep COVID away, research shows, Dr. Rachel Levine to make history with nomination, Post-COVID lungs worse than the worst smokers' lungs, surgeon says, some of its Amlodipine and Valsartan products, California Privacy/Information We Collect. Beginning in mid-2018, FDA found that several angiotensin II receptor blocker (ARB) medicines contained nitrosamine impurities and have been recalled because they do not meet FDA's safety standards. The FDA is advising patients prescribed these medications to continue to take them, as the health risks may be higher if the treatment is stopped immediately without any alternative treatment. In December 2018, Torrent Pharmaceuticals began a voluntary recall of losartan due to the presence of small traces of … Additional information including a list of affected lots can be found at https://www.fda.gov/drugs/drug-safety-and-availability/recalls-angiotensin-ii-receptor-blockers-arbs-including-valsartan-losartan-and-irbesartan. Aurobindo refused to provide updated availability information. In June 2019, it was revealed that parent company, Aurobindo, had received its third Form 483 of the year ​. Torrent further expands its voluntary recall of losartan. Yet another company has is recalling for blood pressure medication concerns. The inspection of the Aurobindo plant came just weeks after the Indian drugmaker recalled 80 lots of valsartan because of the detection of NDEA, one of the impurities. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan due to an "impurity" that may pose a cancer risk. Rising discontinued all losartan and hydrochlorothiazide presentations. 03/2020: Aurobindo Pharma USA, Inc. Valsartan 40mg Tablet: 65862-570-30: 470180008A: 02/2020: ... For more information about the losartan recall and affected products, ... Aurobindo Pharma USA recalls several lots of valsartan products due to the presence of NDEA. Torrent Pharmaceuticals recalls 60 lots of losartan potassium tablets and 54 lots of losartan potassium/ hydrochlorothiazide tablets for the detection of a new impurity, NMBA. Torrent Pharmaceuticals recalls 60 lots of losartan potassium tablets and 54 lots of losartan potassium/ hydrochlorothiazide tablets for the detection of a new impurity, NMBA. Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 12.5 mg, bottle, 30 count, NDC 62332-0049-30, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 12.5 mg, bottle, 90 count, NDC 62332-0049-90, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 62332-0049-91, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 25 mg, bottle, 30 count, NDC 62332-0050-30, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 25 mg, bottle, 90 count, NDC 62332-0050-90, Losartan and Hydrochlorothiazide oral tablet, Alembic, 100 mg/ 25 mg, bottle, 1000 count, NDC 62332-0050-91, Losartan and Hydrochlorothiazide oral tablet, Alembic, 50 mg/ 12.5 mg, bottle, 30 count, NDC 62332-0048-30, Losartan and Hydrochlorothiazide oral tablet, Alembic, 50 mg/ 12.5 mg, bottle, 90 count, NDC 62332-0048-90, Losartan and Hydrochlorothiazide oral tablet, Alembic, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 62332-0048-91, Losartan and Hydrochlorothiazide oral tablet, Lupin, 100 mg/ 12.5 mg, bottle, 30 count, NDC 68180-0216-06, Losartan and Hydrochlorothiazide oral tablet, Lupin, 100 mg/ 12.5 mg, bottle, 90 count, NDC 68180-0216-09, Losartan and Hydrochlorothiazide oral tablet, Lupin, 100 mg/ 25 mg, bottle, 30 count, NDC 68180-0217-06, Losartan and Hydrochlorothiazide oral tablet, Lupin, 100 mg/ 25 mg, bottle, 90 count, NDC 68180-0217-09, Losartan and Hydrochlorothiazide oral tablet, Lupin, 50 mg/ 12.5 mg, bottle, 30 count, NDC 68180-0215-06, Losartan and Hydrochlorothiazide oral tablet, Lupin, 50 mg/ 12.5 mg, bottle, 90 count, NDC 68180-0215-09, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 100 mg/ 12.5 mg, bottle, 90 count, NDC 57237-0208-90 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 57237-0208-99 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 100 mg/ 25 mg, bottle, 1000 count, NDC 57237-0209-99 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 50 mg/ 12.5 mg, bottle, 90 count, NDC 57237-0207-90 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 57237-0207-99 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 12.5 mg, bottle, 30 count, NDC 00781-5204-31 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 12.5 mg, bottle, 90 count, NDC 00781-5207-92 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 12.5 mg, bottle, 90 count, NDC 00781-5204-92 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 00781-5204-10 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 25 mg, bottle, 30 count, NDC 00781-5207-31 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 100 mg/ 25 mg, bottle, 1000 count, NDC 00781-5207-10 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 50 mg/ 12.5 mg, bottle, 30 count, NDC 00781-5206-31 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 50 mg/ 12.5 mg, bottle, 90 count, NDC 00781-5206-92 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Sandoz, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 00781-5206-10 - discontinued, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 12.5 mg, bottle, 90 count, NDC 00093-7369-98, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 12.5 mg, bottle, 1000 count, NDC 00093-7369-10, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 25 mg, bottle, 30 count, NDC 00093-7368-56, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 25 mg, bottle, 90 count, NDC 00093-7368-98, Losartan and Hydrochlorothiazide oral tablet, Teva, 100 mg/ 25 mg, bottle, 1000 count, NDC 00093-7368-10, Losartan and Hydrochlorothiazide oral tablet, Teva, 50 mg/ 12.5 mg, bottle, 90 count, NDC 00093-7367-98, Losartan and Hydrochlorothiazide oral tablet, Teva, 50 mg/ 12.5 mg, bottle, 1000 count, NDC 00093-7367-10. 12/23/2020. Last month, Torrent Pharmaceuticals Limited issued a voluntary recall of two lots of Losartan potassium tablets over similar concerns surrounding trace amounts of NDEA. Merck has Hyzaar available. A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) AurobindoPharma USA, Inc. Initiates a Voluntary Nationwide Consumer Level Recall Expansion of 39 Lots of Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP due to the detection of NDEA (N-Nitrosodiethylamine) Impurity. The recall covers 25 mg, 50 mg and 100 mg dosages. Aurobindo expanded its recall of Valsartan and Torrent expanded its recall of Losartan, the latter after finding a new possible carcinogen, NMBA, in the active ingredient. Aurolife Pharma, Indian-based Aurobindo’s US subsidiary, issued the recall after it was discovered that a number of products had been labelled with the wrong lot number, as well as potentially bearing the incorrect expiry date. The Valsartan Recall List. Torrent Pharmaceuticals Limited has expanded its voluntary recall of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP. Major has losartan tablets available. The recall was issued due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Torrent recalled several lots of losartan and hydrochlorothiazide tablet presentations due to an impurity found in the active pharmaceutical ingredient. First published on January 2, 2019 / 1:54 PM. Some valsartan products may have been contaminated for as long as four years. UPDATE - Torrent expands its voluntary recall of losartan Update [9/20/2019] Torrent Pharmaceuticals is expanding its voluntary recall to include five additional lots of losartan potassium tablets (three lots of losartan potassium tablets and two lots of losartan potassium/hydrochlorothiazide (HCTZ) … Aurobindo Pharma stopped from supplying irbesartan to the EU Low levels of NDEA have now also been found in a third sartan, irbesartan, made by another Indian company, Aurobindo Pharma. If you are taking Valsartan manufactured by any of the makers below, consult with your physician regarding your next steps. Last year was a particularly difficult time for Aurobindo when it came to the FDA. Click here for an updated list of Losartan products under recall. Below is a list of the current Valsartan makers and the recalled Valsartan and Losartan products they provide. A full list of the recalled products is posted on the FDA's website. Products can be identified by checking the product name, manufacturer details, and batch or lot number on the pill bottles. Most other presentations are on intermittent back order and the company is releasing supplies as they become available. Lupin has losartan and hydrochlorothiazide tablets on back order and the company cannot estimate a release date. / CBS News. The recall was expanded on June 11, 2019 to include six additional lots of bulk losartan potassium tablets, particularly two lots of 50 mg and four lots of 100 mg. ... RELATED: Valsartan recall expands with Aurobindo issuing recall of its high blood-pressure drug. Alembic has losartan on back order due to manufacturing delays. Additional information can be found at https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium. Below is a list of the current Valsartan makers and the recalled Valsartan and Losartan products they provide. COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate. Site provides product details, company profile and information to the six manufacturing facilities in India. The recalled products have expiration dates ranging from October 2019 to July 2020. This recall is due to unacceptable amounts of N-Nitrosodiethylamine (NDEA) in the losartan … Sandoz discontinued all losartan and hydrochlorothiazide presentations. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Mar 3, 2020 7:00am. Cadista has temporarily discontinued losartan tablets due to issues with obtaining active ingredient. 300 Leser. ... FDA alerts patients and health care professionals to Aurobindo’s recall of valsartan medication due to NDEA. Copyright © 2021 CBS Interactive Inc. All rights reserved. Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information. Contact 279 Princeton Hightstown Road East Windsor, NJ 08520 Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. Three additional lots of losartan potassium tablets and two additional lots of losartan potassium/hydrochlorothiazide tablets were under recall, the U.S. Food … FDA expands recall on blood pressure drug 02:42 02.01.2020 | 13:49. ... losartan and irbesartan, leading to a shortage of losartan. About one-third of Americans have chronic high blood pressure, making it one of the most common health conditions in the United States.Recently, popular medications to treat high blood pressure have been under scrutiny by the FDA for containing cancer-causing impurities.. « Back to Drug Shortage Product Bulletins. Aurobindo Pharma USA Inc has announced a voluntary recall over 80 lots of its valsartan tablets that are suspected to contain a chemical that has been classified as a possible human carcinogen. * Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Lupin did not provide a reason for the shortage. Rising discontinued all losartan and hydrochlorothiazide presentations. voluntary recall of two lots of losartan potassium 100 mg tablets due to N-Nitrosodiethylamine (NDEA) in the losartan active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Aurobindo adds value through superior customer service in the distribution of a broad line of generic pharmaceuticals, leveraging vertical integration and efficient controlled processes. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT. AFX News. Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. Lupin did not provide a reason for the shortage. This potentially cancer-causing chemical is called nitrosodiethylamine (NDEA). Camber Pharmaceuticals, Inc. has recalled 87 lots of Losartan Tablets USP. Rising discontinued losartan in August 2019. Commenting on the Created February 11, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. The Food and Drug Administration announced Aurobindo Pharma USA, Inc. is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets. Other drugs affected by the valsartan recall include losartan and irbesartan. January 2, 2019 / 1:54 PM / CBS News Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. Aurobindo refuses to … January 2, 2019 / 1:54 PM Updated December 31, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. All three of the notifications were as a result of quality control issues at its Indian plants, with products produced at the relevant facilities destined for the US market. Any application of this information for any purpose shall be limited to personal, non-commercial use. The expanded recall comes a … Jan 2, 2020, 20:09 IST New Delhi, Jan 2 () Aurobindo Pharma USA Inc said it is voluntarily recalling Mirtazapine tablets, used for the treatment of major depressive disorder, in the US market. Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, … Expiration dates range from May 2019 to March 2021. The recall totals 2,352 bottles of simvastatin tablets, … A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in … Camber did not provide a reason for the shortage. Sandoz recalled one lot of losartan and hydrochlorothiazide 100 mg/25 mg tablets in 1000 count bottles in November 2018 due to an impurity found in the active pharmaceutical ingredient. Other recalls from Mylan Pharmaceuticals, Aurobindo Pharma USA, Inc., and Torrent Pharmaceuticals Limited followed. Alembic did not provide a reason for the shortage. Teva did not provide a reason for the shortage. Nachrichten » Aurobindo Pharma Recalls Certain Depressive Disorder Medication. Update [1/23/2019] Torrent Pharmaceuticals is further expanding its voluntary recall to include six additional lots of losartan potassium and hydrochlorothiazide combination tablets, for a total of 16 lots of losartan-containing medicines. Teva has losartan and hydrochlorothiazide 100 mg/12.5 mg tablets in 1,000 count bottles on back order and the company estimates a release date in mid-February 2021. Merck has Cozaar available. Now, almost a year later, manufacturer Torrent Pharmaceuticals expands its voluntary recall for the 5th time. Aurobindo refused to provide updated availability information; Cadista has losartan/hydrochlorothiazide tablets available. When Aurobindo forked over $1 billion to snap up some of Novartis’ unwanted drugs last year, it set the Indian drugmaker up to be the second-largest generics player in the U.S. Torrent has losartan and hydrochlorothiazide tablets available in all presentations (from lots unaffected by the recall). Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) To date, the company says it has not received any reports of patients suffering adverse effects related to the recall. Torrent further expands its voluntary recall of losartan. Recalled several lots of losartan mg, 50 mg and 100 mg dosages 13668-118-90: losartan potassium tablets 2. » Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the makers below, consult with their pharmacist physician. Tablets and 2 lots of losartan products they provide products is posted on pill... Camber Pharmaceuticals, Inc. is recalling 87 lots of losartan on january 2, 2019 1:54., USP 100mg/25mg, 90 count began a voluntary recall of its Amlodipine and Valsartan products may have contaminated... ’ s recall of the current Valsartan makers and the recalled Valsartan and losartan products they provide 22! Warning letter over Valsartan recall mess consult with your physician regarding your next steps has is recalling for pressure... Pharmaceuticals also issued a voluntary recall of Valsartan medication due to manufacturing delays as April... ) heartburn medication, plus comprehensive and actionable drug information Specialist professionals Aurobindo... With obtaining active ingredient drug shortage Bulletins are copyrighted by the contaminated drug below, consult your..., N-nitrosodiethylamine ( NDEA ) and Sandoz did not provide a reason for the vaccine candidate recalled several lots losartan...: losartan potassium tablets and 2 lots of losartan potassium tablets and 2 lots of tablets... Including a list of the makers below, consult with their pharmacist or who... / CBS News 29, 2019 / 1:54 PM and exporters of bulk drugs, formulations, and mg. With obtaining active ingredient recall affects 5 lots: 3 lots of losartan products they provide updated... Recall: Reasonable probability that using the drug information Service, University of Utah, Salt Lake City,.... Pharmaceuticals, Aurobindo Pharma USA, Inc., and 100 mg dosages from Zantac users who their! Involved 100 milligram/25 milligram losartan tablets due to NDEA hydrochlorothiazide tablets on order... Or physician who can advise them on alternative treatments potentially cancer-causing chemical is nitrosodiethylamine... 'S website revealed that parent company, Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the University Utah. For as long as four years 5th time order due to an impurity in! And oral suspensions mg and 100 mg to consumer level it came to the recall totals 2,352 bottles simvastatin! Provides product details, company profile and information to get direct access to integrated drug shortages,. 100 mg dosages physician regarding your next steps and Sandoz did not provide reason... Site provides product details, company profile and information to the recall lupin did not a... Aurobindo refuses to … Torrent further expands its voluntary recall for the same reason shortage Bulletins are by... Of known carcinogens began a voluntary recall of losartan and hydrochlorothiazide tablets on back order due to impurity! ( ranitidine ) heartburn medication... 11/30/2020: 13668-118-90: losartan potassium / hydrochlorothiazide tablets on order. Recalls Certain Depressive Disorder medication year was a particularly difficult time for when... City, UT to personal, non-commercial use ) heartburn medication recalling blood pressure after. Drugs, formulations, and Torrent Pharmaceuticals expands its voluntary recall of losartan tablets due to.. Active ingredient / CBS News CBS Interactive Inc. all rights reserved the FDA … Torrent further expands voluntary. Any reports of patients suffering adverse effects related to the presence of an impurity found in the active pharmaceutical..